A Chieftain of All Progressives Congress (APC). has urged President Bola Tinubu to “direct full enforcement of the executive order” on reduction in prices of essential medical consumables and machine ...

Recently, President Trump signed a “most-favored nation” executive order on drug prices with a claim that it would force pharmaceutical companies to lower U.S. prescription costs to match those abroad ...

The pharmaceutical giant and Novo Nordisk said they would lower the prices of their popular weight loss drugs to expand ...

The price of Novo Nordisk's blockbuster diabetes and weight loss-related drug Ozempic will be cut, according to President Donald Trump. Trump said this week during a White House event on fertility ...

Eli Lilly and Novo Nordisk will lower prices for GLP-1 receptor agonists, aligning with the Most Favored Nation executive order to address US drug pricing disparities. Novo Nordisk's semaglutide ...

President Trump signed an executive action Tuesday intended to lower prescription drug prices for Americans. A White House official, speaking on condition of anonymity, told reporters ahead of the ...

The other new piece to MFN in its current incarnation is the direct-to-patient platform TrumpRX, and the promise that MFN ...

WASHINGTON (AP) — AstraZeneca on Friday became the second major pharmaceutical manufacturer to announce it had agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the ...

AtraZeneca has agreed to lower drug prices for Medicaid under a deal with the Trump administration, matching the lowest global prices for its drugs. The deal follows a similar agreement with Pfizer ...

Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. "Competition is leading to lower prices, better value, and ...

ZURICH, Sept 14 (Reuters) - President Donald Trump's latest executive order aimed at lowering U.S. drug prices by linking them to those of other nations is "light on details" but "surely exceeds" his ...

The MFN policy seeks to align US drug prices with international benchmarks, affecting company pricing strategies and behavior. Tariffs on foreign-manufactured drugs could increase patient costs, ...